Vitamin K Fracture Risk Meta-analysis: What the Evidence Says
Vitamin K Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Quick Answer
Vitamin K Fracture Risk Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Vitamin K Fracture Risk Meta-analysis: What the Evidence Says
Quick Answer
Vitamin K Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis | systematic review | 1 | 2026-01-01 | 10.1136/bmj-2025-088050 |
| Polypharmacy and Bone Health in Patients with Type 2 Diabetes Mellitus: A Narrative Review | preclinical study | 4 | 2026-05-01 | 10.11005/jbm.25.975 |
What The Sources Report
- Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé Olivier (2026); evidence level 1]
- If unpublished data, not obtained through personal communications, were found in another systematic review, we used that review to complete data extraction. [Massé Olivier (2026); evidence level 1]
- Fracture is a common complication of DM, especially those with longer diabetes duration, vascular complications, and due to the use of specific medications. BMD is a usual significant indicator of bone health and a primary predictor of fracture risk. [Kashmoola Israa O. (2026); evidence level 4]
- A low BMD means weaker bones and is often indicative of osteoporosis. Evidence stares that T2DM patients routinely reveal average or augmented BMD levels compared to those with type 1 DM (T1DM) or those without T2DM; nevertheless, they experience inappropriate risk of fractures. [Kashmoola Israa O. (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin K fracture risk meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Massé Olivier (2026). Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. DOI: 10.1136/bmj-2025-088050. PMCID: PMC13188451. PMID: 42161415. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13188451/
- Kashmoola Israa O. (2026). Polypharmacy and Bone Health in Patients with Type 2 Diabetes Mellitus: A Narrative Review. DOI: 10.11005/jbm.25.975. PMCID: PMC13284594. PMID: 42316445. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Acces.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13284594/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed August 6, 2026 by Migaku Evidence Review
Related content
Supplement
Vitamin C
A potent water-soluble antioxidant that protects cells, supports collagen synthe…
Supplement
Vitamin K2
A critical vitamin that directs calcium into the bones and teeth while preventin…
Supplement
Vitamin D3
A fat-soluble vitamin crucial for calcium absorption, bone health, immune functi…
Supplement
Vitamin K2 (MK-7)
The missing partner to vitamin D3 — directs calcium into bones and away from art…
